Phase I and pharmacokinetic study of carboplatin and paclitaxel with a biweekly schedule in patients...
Phase I and pharmacokinetic study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer
About this item
Full title
Publisher
Berlin: Springer
Journal title
Language
English
Formats
Publication information
Publisher
Berlin: Springer
Subjects
More information
Scope and Contents
Contents
A phase I study was conducted to determine the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT) of carboplatin in combination with paclitaxel using a biweekly schedule in patients with advanced non-small-cell lung cancer (NSCLC).
The pharmacokinetics of paclitaxel were determined preliminarily in some patients. The criteria for elig...
Alternative Titles
Full title
Phase I and pharmacokinetic study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_757274146
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_757274146
Other Identifiers
ISSN
0344-5704
E-ISSN
1432-0843
DOI
10.1007/s00280-003-0627-7
